| Lactose (India) Ltd | 106 Cr. | 84.5 | 137/80.0 | 22.0 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.15 Cr. | 1.65 | 3.17/1.57 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 2,880 Cr. | 264 | 479/222 | 60.3 | 24.3 | 0.25 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 27.9 Cr. | 35.8 | 68.4/35.1 | | 10.1 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 107 Cr. | 73.0 | 74.5/17.0 | 428 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 88.5 Cr. | 87.4 | 115/69.7 | 25.3 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 59,141 Cr. | 2,096 | 2,298/1,336 | 21.8 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 211 Cr. | 8.67 | 17.2/8.30 | 12.0 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.09 Cr. | 12.0 | 14.8/9.35 | 88.6 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 905 Cr. | 1,686 | 1,999/635 | 26.6 | 294 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 85.9 Cr. | 17.2 | 29.8/16.2 | 24.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,006 Cr. | 342 | 399/241 | 11.4 | 133 | 0.73 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.09 Cr. | 14.7 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 6.52 Cr. | 2.62 | 6.11/2.38 | 3.70 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 219 Cr. | 226 | 536/225 | 37.6 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 5,334 Cr. | 1,226 | 1,511/944 | 45.8 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 1.12/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 27.0 Cr. | 10.2 | 26.3/7.45 | 13.2 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 6.09 Cr. | 6.03 | 12.5/5.65 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 136 Cr. | 381 | 785/379 | 9.52 | 596 | 0.39 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 71.6 Cr. | 71.6 | 92.5/29.0 | 135 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 10,871 Cr. | 1,039 | 2,150/1,018 | 34.2 | 174 | 1.03 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 5.48 Cr. | 43.5 | 87.9/36.1 | 11.2 | 39.2 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 5.01 | 7.66/2.99 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 15.1 Cr. | 101 | 153/75.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 25.8 Cr. | 47.1 | 144/12.2 | 12.5 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 23.7 Cr. | 31.4 | 61.5/31.4 | 38.3 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.30 Cr. | 21.0 | 24.4/15.7 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 6,130 Cr. | 353 | 1,028/336 | 20.9 | 72.4 | 0.34 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 70.4 Cr. | 16.3 | 28.8/15.7 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 10.3 Cr. | 20.3 | 30.0/15.9 | 1,030 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 83,556 Cr. | 2,024 | 2,727/1,910 | 47.3 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 214 Cr. | 371 | 524/241 | 20.5 | 123 | 1.21 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 69.6 Cr. | 48.5 | 51.9/26.7 | 94.0 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 75,957 Cr. | 1,308 | 1,330/994 | 21.5 | 603 | 0.31 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 165 Cr. | 265 | 317/159 | 56.0 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 713 Cr. | 71.1 | 115/68.0 | 17.0 | 32.6 | 2.11 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 25.6 Cr. | 19.6 | 39.7/19.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 20,691 Cr. | 2,527 | 2,580/930 | 72.1 | 173 | 0.06 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.29 Cr. | 0.65 | 0.97/0.50 | 61.3 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 201 Cr. | 26.2 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 7.31 Cr. | 12.5 | 19.1/7.60 | 244 | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 126 Cr. | 5.35 | 6.80/3.00 | 293 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 56,111 Cr. | 26,405 | 37,000/25,350 | 36.8 | 1,888 | 1.80 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,793 Cr. | 639 | 972/557 | 26.8 | 226 | 0.78 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 176 Cr. | 62.0 | 100/32.8 | 51.2 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 3,852 Cr. | 1,131 | 1,740/752 | | 93.5 | 0.09 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 19,454 Cr. | 1,197 | 1,870/1,087 | 179 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 830 Cr. | 238 | 330/162 | 19.3 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 48.4 Cr. | 5.84 | 29.4/5.70 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,174 Cr. | 878 | 950/278 | 15.4 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,103 Cr. | 299 | 712/296 | 20.0 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,118 Cr. | 791 | 1,402/765 | 16.0 | 768 | 1.26 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,45,447 Cr. | 4,298 | 4,483/3,101 | 63.1 | 250 | 0.74 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 691 Cr. | 75.1 | 179/69.2 | | 41.3 | 0.67 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,087 Cr. | 11.6 | 23.5/11.0 | 15.8 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 11,712 Cr. | 306 | 1,250/267 | 39.0 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,530 Cr. | 134 | 303/113 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,30,777 Cr. | 1,795 | 1,851/1,547 | 35.5 | 324 | 0.89 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,020 Cr. | 457 | 734/425 | | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,789 Cr. | 405 | 434/175 | 43.4 | 81.2 | 0.10 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,753 Cr. | 345 | 502/260 | 38.2 | 125 | 0.14 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 7,641 Cr. | 3,318 | 6,718/3,203 | 22.0 | 326 | 3.53 % | 57.5 % | 43.0 % | 10.0 |
| RPG Life Sciences Ltd | 3,178 Cr. | 1,922 | 2,725/1,731 | 30.2 | 335 | 1.04 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,195 Cr. | 4,937 | 6,739/4,725 | 27.9 | 373 | 2.53 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 112 Cr. | 31.9 | 73.4/30.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,545 Cr. | 4,710 | 5,993/3,701 | 28.3 | 841 | 0.74 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 107 Cr. | 86.6 | 122/81.0 | 7.66 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,012 Cr. | 328 | 582/305 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 2,696 Cr. | 532 | 899/489 | 104 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 15,519 Cr. | 12,096 | 19,748/10,060 | 86.6 | 1,263 | 0.10 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 200 Cr. | 10.3 | 28.3/10.1 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 17,440 Cr. | 974 | 1,060/660 | 11.2 | 483 | 0.62 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,026 Cr. | 37.0 | 70.5/33.5 | 26.5 | 21.8 | 0.54 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,486 Cr. | 165 | 271/156 | 20.8 | 59.3 | 0.48 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 47.4 Cr. | 29.9 | 95.0/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 182 Cr. | 51.1 | 129/47.1 | | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,07,327 Cr. | 2,348 | 2,378/1,774 | 21.6 | 430 | 0.51 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,197 Cr. | 598 | 679/440 | 13.6 | 357 | 0.30 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 55,254 Cr. | 1,024 | 1,141/517 | 69.0 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,511 Cr. | 1,457 | 1,740/666 | 26.4 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 102 Cr. | 47.1 | 114/45.8 | | 74.6 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 587 Cr. | 122 | 215/111 | 35.5 | 104 | 2.47 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 534 Cr. | 153 | 250/133 | 20.5 | 75.9 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 13,695 Cr. | 860 | 1,250/784 | 29.7 | 414 | 0.58 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 33,481 Cr. | 2,085 | 2,195/1,303 | 44.4 | 243 | 0.74 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,234 Cr. | 184 | 302/155 | 29.0 | 37.9 | 1.36 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 39,832 Cr. | 1,570 | 1,624/1,168 | 37.7 | 293 | 0.25 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,307 Cr. | 78.6 | 127/57.5 | 18.5 | 59.7 | 1.27 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 19.9/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 1,117 Cr. | 137 | 152/67.2 | 23.6 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,716 Cr. | 186 | 350/181 | | 106 | 0.11 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,039 Cr. | 165 | 457/155 | 81.5 | 96.9 | 0.85 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,173 Cr. | 1,379 | 2,350/1,243 | 28.6 | 397 | 0.51 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 2,955 Cr. | 295 | 409/268 | 58.5 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 15,265 Cr. | 629 | 640/412 | 28.1 | 164 | 0.24 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 61,195 Cr. | 2,168 | 2,298/1,336 | 22.6 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 39,329 Cr. | 2,322 | 3,516/2,220 | 39.1 | 101 | 1.81 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 28,182 Cr. | 1,710 | 2,131/1,200 | 23.7 | 610 | 1.05 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 5,371 Cr. | 330 | 528/322 | 23.2 | 149 | 1.52 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 18,511 Cr. | 1,336 | 1,910/1,097 | 41.7 | 227 | 0.55 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,08,563 Cr. | 1,301 | 1,380/1,020 | 19.5 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 2,415 Cr. | 154 | 322/141 | 18.3 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,00,520 Cr. | 1,244 | 1,673/1,216 | 21.1 | 408 | 1.04 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 12,128 Cr. | 1,596 | 2,397/1,551 | 19.8 | 416 | 0.38 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 138 Cr. | 46.8 | 166/45.3 | 6.38 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 2,371 Cr. | 224 | 244/105 | 21.4 | 107 | 0.22 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 47.2 Cr. | 29.0 | 57.2/28.0 | 17.0 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 61,538 Cr. | 380 | 425/295 | 74.9 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,218 Cr. | 1,202 | 2,000/990 | 28.3 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 106 Cr. | 66.9 | 129/64.0 | 13.1 | 49.2 | 1.79 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 278 Cr. | 118 | 205/70.6 | 24.3 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,038 Cr. | 8,415 | 10,691/6,502 | 101 | 320 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,501 Cr. | 519 | 791/497 | 26.0 | 118 | 0.89 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 119 Cr. | 56.7 | 120/54.6 | 10.1 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 64,990 Cr. | 5,436 | 5,934/4,612 | 27.1 | 1,116 | 0.83 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 13,644 Cr. | 694 | 1,108/635 | 20.6 | 271 | 1.58 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 370 Cr. | 649 | 959/601 | 38.6 | 690 | 0.77 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 35,980 Cr. | 2,880 | 3,228/2,022 | 35.5 | 345 | 0.97 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,072 Cr. | 274 | 367/259 | 21.3 | 133 | 1.89 % | 13.1 % | 9.54 % | 2.00 |
| Industry Average | 20,099.65 Cr | 1,064.10 | | 54.22 | 201.20 | 0.40% | 16.35% | 15.16% | 6.10 |